卓昇有限公司–最專業科學研究供應商
RKO is a poorly differentiated colon carcinoma cell line developed by Michael Brattain. RKO cells contain wild-type p53 but lack endogenous human thyroid receptor nuclear receptor (h-TRbeta1).
ABC-TC0975
RKO
Human
Tumor Cell Lines
1 vial
Dry Ice
Liquid Nitrogen
Accegen Biotechnology